METLIFE INC
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 7. Results of Operations
Results of Operations
MetLife is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management. MetLife is organized into six segments: Group Benefits; RIS; Asia; Latin America; EMEA; and MetLife Holdings. In addition, the Company reports certain of its results of operations in Corporate & Other. See “Business — Segments and Corporate & Other” and Note 2 of the Notes to the Consolidated Financial Statements for further information on the Company’s segments and Corporate & Other.
Key Financial Highlights
Net income available to MetLife, Inc.’s common shareholders was $4.2 billion and $1.4 billion for the years ended December 31, 2024 and 2023, respectively.
Adjusted earnings available to common shareholders was $5.8 billion and $5.5 billion for the years ended December 31, 2024 and 2023, respectively.
Consolidated Results
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Revenues | ||
| Premiums | $44,945 | $44,283 |
| Universal life and investment-type product policy fees | 4,974 | 5,152 |
| Net investment income | 21,273 | 19,908 |
| Other revenues | 2,601 | 2,526 |
| Net investment gains (losses) | (1,184) | (2,824) |
| Net derivative gains (losses) | (1,623) | (2,140) |
| Total revenues | 70,986 | 66,905 |
| Expenses | ||
| Policyholder benefits and claims and policyholder dividends | 45,323 | 45,212 |
| Policyholder liability remeasurement (gains) losses | (206) | (45) |
| Market risk benefit remeasurement (gains) losses | (1,109) | (994) |
| Interest credited to policyholder account balances | 8,339 | 7,860 |
| Amortization of deferred policy acquisition costs, value of business acquired and negative value of business acquired | 2,021 | 1,926 |
| Interest expense on debt | 1,037 | 1,045 |
| Other expenses, net of capitalization of deferred policy acquisition costs | 9,959 | 9,739 |
| Total expenses | 65,364 | 64,743 |
| Income (loss) before provision for income tax | 5,622 | 2,162 |
| Provision for income tax expense (benefit) | 1,178 | 560 |
| Net income (loss) | 4,444 | 1,602 |
| Less: Net income (loss) attributable to noncontrolling interests | 18 | 24 |
| Net income (loss) attributable to MetLife, Inc. | 4,426 | 1,578 |
| Less: Preferred stock dividends | 200 | 198 |
| Net income (loss) available to MetLife, Inc.’s common shareholders | $4,226 | $1,380 |
Net income (loss) available to MetLife, Inc.’s common shareholders - Increased $2.8 billion primarily due to the following:
Net Investment Gains (Losses)(1) - Favorable change of $1.6 billion ($1.3 billion, net of income tax):
Impairment losses in 2023 for investments disposed of in connection with a reinsurance transaction that closed in November 2023
Lower losses on sales of fixed maturity securities
Higher gains on sales of real estate investments
Net Derivative Gains (Losses)(2) - Favorable change of $517 million ($408 million, net of income tax)(3):
Key equity indexes increased less in 2024 compared to 2023 - favorable impact to the estimated fair value of long put options and short futures
Certain long-term interest rates increased more significantly in 2024 compared to 2023 and other long-term interest rates increased in 2024 compared to decreased in 2023 - unfavorable impact to the estimated fair value of receiver swaps
Market Risk Benefit Remeasurement (Gains) Losses(4) - Favorable change of $115 million ($91 million, net of income tax):
Certain long-term interest rates increased more significantly in 2024 compared to 2023 and other long-term interest rates increased in 2024 compared to decreased in 2023
Key equity indexes increased less in 2024 compared to 2023
Actuarial Assumption Review - Favorable change of $70 million ($55 million, net of income tax):
| Years Ended December 31, · Variance | |||
|---|---|---|---|
| 2024 · 2023 | |||
| Assumptions · (In millions, net of income tax) | |||
| Economic | $(55) | $(40) | $(15) |
| Mortality | 110 | 51 | 59 |
| Morbidity | 53 | (14) | 67 |
| Policyholder behavior | (91) | — | (91) |
| Operational | 47 | 12 | 35 |
| Total | $64 | $9 | $55 |
Total results for 2024 and 2023 include gains of $64 million and $9 million, respectively:
Of the $64 million gain, a loss of $5 million was recognized in MRB remeasurement (gains) losses, a loss of $1 million was recognized in net derivative gains (losses), both of which are discussed above, and a gain of $70 million was recognized in adjusted earnings available to common shareholders, which is discussed below
Of the $9 million gain, a loss of $4 million was recognized in MRB remeasurement (gains) losses, a loss of $2 million was recognized in net derivative gains (losses), both of which are discussed above, and a gain of $15 million was recognized in adjusted earnings available to common shareholders, which is discussed below
The $55 million increase was primarily driven by (i) favorable mortality experience in the RIS segment in the current year, (ii) updates made in the prior year to morbidity assumptions in the MetLife Holdings segment associated with an increase in incident rates for the long-term care business, and (iii) updates to policyholder behavior assumptions in the Asia segment related to lapse assumptions in the accident & health business, partially offset by updates to policyholder behavior assumptions in the MetLife Holdings segment related to claim utilization experience for the long-term care business
Adjusted Earnings Available to Common Shareholders(5) - Favorable change of $271 million. See “— Consolidated Results — Adjusted Earnings Available to Common Shareholders.”
Taxes - Favorable change in effective tax rate - 21% in 2024 compared to 26% in 2023:
2024 effective tax rate on income before provision for income tax was equal to the U.S. statutory rate of 21% primarily due to tax benefits from:
Low income housing and other tax credits, partially offset by the impact of tax equity investments now accounted for under the proportional amortization method
Offset by tax charges from:
Adjustments related to prior years’ taxes
2023 effective tax rate on income before provision for income tax was 26% compared to the U.S. statutory rate of 21% primarily due to tax charges from:
Non-taxable investment loss
Partially offset by tax credits from:
Low income housing and other tax credits
(1)See “— Investments — Overview” and “— Investments — Investment Portfolio Results — Net Investment Gains (Losses)” for information regarding management of our investment portfolio.
(2)See “— Derivatives — Net Derivative Gains (Losses)” for information regarding the use of derivatives to hedge market risk.
(3)Includes amounts relating to investment hedge adjustments, which are also included in adjusted earnings available to common shareholders. See “— Investments — Investment Portfolio Results” for additional information.
(4)See Note 6 of the Notes to the Consolidated Financial Statements for further information on the Company’s MRBs.
(5)See “— Non-GAAP and Other Financial Disclosures” for information regarding adjusted earnings and related measures.
Reconciliation of net income (loss) to adjusted earnings available to common shareholders and premiums, fees and other revenues to adjusted premiums, fees and other revenues
Year Ended December 31, 2024
| Group Benefits · RIS · Asia · Latin America · EMEA · MetLife Holdings · Corporate & Other · Total | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (In millions) | ||||||||||||||||
| Net income (loss) available to MetLife, Inc.'s common shareholders | $1,596 | $1,138 | $723 | $522 | $269 | $697 | $(719) | $4,226 | ||||||||
| Add: Preferred stock dividends | — | — | — | — | — | — | 200 | 200 | ||||||||
| Add: Net income (loss) attributable to noncontrolling interests | — | — | — | — | 4 | (1) | 15 | 18 | ||||||||
| Add: Preferred stock redemption premium | — | — | — | — | — | — | — | — | ||||||||
| Net income (loss) | 1,596 | 1,138 | 723 | 522 | 273 | 696 | (504) | 4,444 | ||||||||
| Less: adjustments from net income (loss) to adjusted earnings available to common shareholders: | ||||||||||||||||
| Revenues: | ||||||||||||||||
| Net investment gains (losses) | (58) | (501) | (591) | 28 | (40) | (408) | 386 | (1,184) | ||||||||
| Net derivative gains (losses) | 118 | 278 | (1,108) | (257) | (19) | (540) | (95) | (1,623) | ||||||||
| Premiums | 31 | — | — | — | — | — | — | 31 | ||||||||
| Universal life and investment-type product policy fees | — | — | — | — | — | — | — | — | ||||||||
| Net investment income | (74) | (191) | 441 | (42) | 625 | (183) | 25 | 601 | ||||||||
| Other revenues | — | (76) | — | — | — | 158 | 28 | 110 | ||||||||
| Expenses: | ||||||||||||||||
| Policyholder benefits and claims and policyholder dividends | (19) | (141) | 255 | (148) | — | 71 | — | 18 | ||||||||
| Policyholder liability remeasurement gains (losses) | — | — | — | — | — | — | — | — | ||||||||
| Market risk benefit remeasurement gains (losses) | — | (11) | (7) | — | 54 | 1,074 | (1) | 1,109 | ||||||||
| Interest credited to policyholder account balances (“PABs”) | — | 2 | (372) | (81) | (624) | (109) | — | (1,184) | ||||||||
| Capitalization of deferred policy acquisition costs (“DAC”) | — | — | — | — | — | — | — | — | ||||||||
| Amortization of DAC, VOBA and negative VOBA | — | — | — | — | — | — | — | — | ||||||||
| Interest expense on debt | — | — | — | — | — | — | — | — | ||||||||
| Other expenses | (11) | (30) | 3 | 7 | (4) | (1) | (81) | (117) | ||||||||
| Goodwill impairment | — | — | — | — | — | — | — | — | ||||||||
| Provision for income tax (expense) benefit | 3 | 141 | 481 | 134 | (2) | (13) | (57) | 687 | ||||||||
| Adjusted earnings | $1,606 | $1,667 | $1,621 | $881 | $283 | $647 | $(709) | $5,996 | ||||||||
| Less: Preferred stock dividends | — | — | — | — | — | — | 200 | 200 | ||||||||
| Adjusted earnings available to common shareholders | $1,606 | $1,667 | $1,621 | $881 | $283 | $647 | $(909) | $5,796 | ||||||||
| Premiums, fees and other revenues | $24,901 | $8,518 | $6,757 | $5,936 | $2,548 | $3,430 | $430 | $52,520 | ||||||||
| Less: adjustments to premiums, fees and other revenues | 31 | (76) | — | — | — | 158 | 28 | 141 | ||||||||
| Adjusted premiums, fees and other revenues | $24,870 | $8,594 | $6,757 | $5,936 | $2,548 | $3,272 | $402 | $52,379 | ||||||||
Year Ended December 31, 2023
| Group Benefits · RIS · Asia · Latin America · EMEA · MetLife Holdings · Corporate & Other · Total | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (In millions) | ||||||||||||||||
| Net income (loss) available to MetLife, Inc.'s common shareholders | $1,521 | $942 | $(150) | $652 | $253 | $(1,338) | $(500) | $1,380 | ||||||||
| Add: Preferred stock dividends | — | — | — | — | — | — | 198 | 198 | ||||||||
| Add: Net income (loss) attributable to noncontrolling interests | — | — | 2 | 7 | 4 | — | 11 | 24 | ||||||||
| Add: Preferred stock redemption premium | — | — | — | — | — | — | — | — | ||||||||
| Net income (loss) | 1,521 | 942 | (148) | 659 | 257 | (1,338) | (291) | 1,602 | ||||||||
| Less: adjustments from net income (loss) to adjusted earnings available to common shareholders: | ||||||||||||||||
| Revenues: | ||||||||||||||||
| Net investment gains (losses) | (56) | (563) | (1,019) | 1 | 10 | (1,914) | 717 | (2,824) | ||||||||
| Net derivative gains (losses) | 39 | 120 | (921) | 89 | (44) | (1,350) | (73) | (2,140) | ||||||||
| Premiums | — | — | — | — | — | — | — | — | ||||||||
| Universal life and investment-type product policy fees | — | — | — | — | — | — | — | — | ||||||||
| Net investment income | (153) | (449) | 350 | (34) | 688 | (260) | 17 | 159 | ||||||||
| Other revenues | — | (75) | — | — | 1 | 29 | 40 | (5) | ||||||||
| Expenses: | ||||||||||||||||
| Policyholder benefits and claims and policyholder dividends | — | (32) | 183 | (157) | — | 11 | — | 5 | ||||||||
| Policyholder liability remeasurement (gains) losses | — | — | — | — | — | — | — | — | ||||||||
| Market risk benefit remeasurement (losses) gains | — | 29 | 43 | — | 40 | 882 | — | 994 | ||||||||
| Interest credited to PABs | — | — | (395) | (149) | (687) | (20) | — | (1,251) | ||||||||
| Capitalization of DAC | — | — | — | — | — | — | — | — | ||||||||
| Amortization of DAC, VOBA and negative VOBA | — | — | — | — | — | — | — | — | ||||||||
| Interest expense on debt | — | — | — | — | — | — | — | — | ||||||||
| Other expenses | — | — | 1 | 8 | (5) | — | (97) | (93) | ||||||||
| Goodwill impairment | — | — | — | — | — | — | — | — | ||||||||
| Provision for income tax (expense) benefit | 36 | 204 | 328 | 61 | (11) | 551 | (135) | 1,034 | ||||||||
| Adjusted earnings | $1,655 | $1,708 | $1,282 | $840 | $265 | $733 | $(760) | $5,723 | ||||||||
| Less: Preferred stock dividends | — | — | — | — | — | — | 198 | 198 | ||||||||
| Adjusted earnings available to common shareholders | $1,655 | $1,708 | $1,282 | $840 | $265 | $733 | $(958) | $5,525 | ||||||||
| Adjusted earnings available to common shareholders on a constant currency basis (1) | $1,655 | $1,708 | $1,248 | $791 | $253 | $733 | $(958) | $5,430 | ||||||||
| Premiums, fees and other revenues | $23,929 | $8,757 | $6,969 | $5,727 | $2,347 | $3,737 | $495 | $51,961 | ||||||||
| Less: adjustments to premiums, fees and other revenues | — | (75) | — | — | 1 | 29 | 40 | (5) | ||||||||
| Adjusted premiums, fees and other revenues | $23,929 | $8,832 | $6,969 | $5,727 | $2,346 | $3,708 | $455 | $51,966 | ||||||||
| Adjusted premiums, fees and other revenues on a constant currency basis (1) | $23,929 | $8,832 | $6,608 | $5,392 | $2,271 | $3,708 | $455 | $51,195 | ||||||||
(1)Amounts for Group Benefits, RIS, MetLife Holdings and Corporate & Other are shown on a reported basis, as constant currency impact is not significant.
Consolidated Results — Adjusted Earnings Available to Common Shareholders
Business Overview. Adjusted premiums, fees and other revenues for the year ended December 31, 2024 increased $413 million, or 1%, compared to 2023. Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $1.2 billion, or 2%, compared to 2023, primarily due to growth in both core and voluntary products in the Group Benefits segment and strong sales and solid persistency across the region in the Latin America segment, partially offset by the expected decline in the MetLife Holdings segment from business run-off.
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Group Benefits | $1,606 | $1,655 |
| RIS | 1,667 | 1,708 |
| Asia | 1,621 | 1,282 |
| Latin America | 881 | 840 |
| EMEA | 283 | 265 |
| MetLife Holdings | 647 | 733 |
| Corporate & Other | (909) | (958) |
| Adjusted earnings available to common shareholders | $5,796 | $5,525 |
| Adjusted earnings available to common shareholders on a constant currency basis | $5,796 | $5,430 |
| Adjusted premiums, fees and other revenues | $52,379 | $51,966 |
| Adjusted premiums, fees and other revenues on a constant currency basis | $52,379 | $51,195 |
Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.
Adjusted Earnings Available to Common Shareholders - Increased $271 million on a reported basis, primarily due to the following business drivers:
Reinsurance Transaction - Decreased adjusted earnings available to common shareholders by approximately $170 million as a result of the reinsurance transaction that closed in November 2023 in the MetLife Holdings segment
Foreign Currency - Decreased adjusted earnings available to common shareholders by $95 million, primarily in the Latin America and Asia segments
Market Factors - Increased adjusted earnings available to common shareholders by $217 million:
Variable investment income increased- higher returns on private equity funds
Recurring investment income increased- higher yields on fixed income securities and mortgage loans, as well as the impact of tax equity investments now accounted for under the proportional amortization method, partially offset by lower income on derivatives and real estate investments
Higher average interest crediting rates on investment-type and certain insurance products, primarily in the RIS and Asia segments
Volume Growth - Increased adjusted earnings available to common shareholders by $194 million:
Higher average invested assets, primarily in the RIS and Latin America segments
Higher sales and business growth in the EMEA and Latin America segments
Increase in interest credited expenses on long duration products, primarily in the RIS segment
Underwriting and Other Insurance Adjustments - Increased adjusted earnings available to common shareholders by $190 million:
Favorable mortality results, primarily in the Group Benefits segment, higher surrender charges in the Asia segment, and favorable morbidity experience in the MetLife Holdings segment, partially offset by unfavorable morbidity experience in the Group Benefits segment
Favorable change from refinements to certain insurance assets and other liabilities in both years, primarily in the Asia and Group Benefits segments, partially offset by an unfavorable change to certain insurance liabilities in the RIS segment
Expenses - Decreased adjusted earnings available to common shareholders by $122 million:
Higher direct expenses, including employee-related and technology costs, in most of the segments
Higher litigation reserves
Lower corporate-related expenses, primarily in Corporate & Other
Taxes - Unfavorable change in effective tax rate - 24% in 2024 compared to 22% in 2023:
2024 effective tax rate on income before provision for income tax was 24% compared to the U.S. statutory rate of 21% primarily due to tax charges from:
Partially offset by tax benefits from:
Low income housing and other tax credits, partially offset by the impact of tax equity investments now accounted for under the proportional amortization method
2023 effective tax rate on income before provision for income tax was 22% compared to the U.S. statutory rate of 21% primarily due to tax charges from:
Partially offset by tax benefits from:
Low income housing and other tax credits
Notable Items - Actuarial assumption review and other insurance adjustments, litigation reserves and settlement costs, and tax adjustments - Increased adjusted earnings available to common shareholders by $88 million on a reported basis:
| Years Ended December 31, · Variance | |||
|---|---|---|---|
| 2024 · 2023 | |||
| (In millions, net of income tax) | |||
| Group Benefits | $(58) | $27 | $(85) |
| RIS | 104 | 61 | 43 |
| Asia | (41) | (94) | 53 |
| Latin America | 4 | — | 4 |
| EMEA | (5) | 18 | (23) |
| MetLife Holdings | 12 | 2 | 10 |
| Corporate & Other | 10 | (76) | 86 |
| Total | $26 | $(62) | $88 |
Segment Results and Corporate & Other
Business Overview. Adjusted premiums, fees and other revenues for the year ended December 31, 2024 increased $941 million, or 4%, compared to 2023, primarily driven by growth in both core and voluntary products, partially offset by a decrease in premiums related to our participating life contracts, which can fluctuate with claims experience.
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Adjusted earnings | $1,606 | $1,655 |
| Adjusted premiums, fees and other revenues | $24,870 | $23,929 |
Adjusted Earnings - Decreased $49 million primarily due to the following business drivers:
Market Factors- Decreased adjusted earnings by $27 million:
Recurring investment income decreased - lower income on derivatives, partially offset by higher yields on fixed income securities
Volume Growth - Increased adjusted earnings by $18 million:
Growth in both core and voluntary products
Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $88 million:
Favorable mortality - primarily due to lower claims incidence in our life business
Favorable change from refinements to certain insurance and other liabilities in both years
Unfavorable morbidity - (i) higher incidence in the accident & health business, (ii) higher claims in vision, and (iii) higher utilization and the impact of prior year development in dental, partially offset by (a) favorable claims experience and rate actions in our pet insurance business and (b) higher recoveries and a favorable reserve adjustment in 2024 in our disability business
Expenses - Decreased adjusted earnings by $43 million:
Higher legal plan utilization and higher technology, employee-related and various other operating expenses exceeded the corresponding increase in adjusted premiums, fees and other revenues
Notable Items - Decreased adjusted earnings by $85 million:
2024 notable items - unfavorable impact of $58 million - actuarial assumption review and other insurance adjustments, which includes an unfavorable refinement on certain life policies
2023 notable item - favorable impact of $27 million - actuarial assumption review
Retirement & Income Solutions
Business Overview. Adjusted premiums, fees and other revenues for the year ended December 31, 2024 decreased $238 million, or 3%, compared to 2023. The decrease was primarily driven by lower premiums from our pension risk transfer and post-retirement benefit businesses, largely offset by growth in our U.K. longevity reinsurance and institutional income annuities businesses. Changes in premiums were partially offset by a corresponding change in policyholder benefits, both of which are reported net of ceded reinsurance.
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Adjusted earnings | $1,667 | $1,708 |
| Adjusted premiums, fees and other revenues | $8,594 | $8,832 |
Adjusted Earnings- Decreased $41 million primarily due to the following business drivers:
Market Factors- Decreased adjusted earnings by $97 million:
Higher average interest crediting rates primarily on investment-type products
Variable investment income increased - higher returns on private equity funds
Recurring investment income increased - higher yields on fixed income securities and mortgage loans, partially offset by lower income on derivatives
Volume Growth- Increased adjusted earnings by $62 million:
Positive flows from pension risk transfer transactions and funding agreement issuances resulted in higher average invested assets
Increase in interest credited expenses on long duration products
Underwriting and Other Insurance Adjustments- Decreased adjusted earnings by $32 million:
Unfavorable refinements to certain insurance liabilities
Expenses - Decreased adjusted earnings by $39 million:
Higher expenses, including certain employee-related costs
Notable Items - Increased adjusted earnings by $43 million:
2024 notable item - favorable impact of $104 million - actuarial assumption review
2023 notable item - favorable impact of $61 million - actuarial assumption review
Asia
Business Overview. Adjusted premiums, fees and other revenues for the year ended December 31, 2024 decreased $212 million, or 3%, compared to 2023. Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $149 million, or 2%, compared to 2023, as increases in premiums in Korea and Australia, as well as fee income from Japan’s foreign currency life and annuity products, were partially offset by a decrease in premiums from Japan’s accident & health and yen-denominated life products.
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Adjusted earnings | $1,621 | $1,282 |
| Adjusted earnings on a constant currency basis | $1,621 | $1,248 |
| Adjusted premiums, fees and other revenues | $6,757 | $6,969 |
| Adjusted premiums, fees and other revenues on a constant currency basis | $6,757 | $6,608 |
Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.
Adjusted Earnings - Increased $339 million on a reported basis, primarily due to the following business drivers:
Foreign Currency - Decreased adjusted earnings by $34 million:
Japanese yen and Korean won weakened against the U.S. dollar
Market Factors - Increased adjusted earnings by $193 million:
Variable investment income increased - higher returns on private equity funds
Recurring investment income increased - higher yields on fixed income securities
Higher average interest crediting rates on investment-type and certain insurance products
Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $89 million:
Higher surrender charges in Japan
Favorable change from refinements to certain insurance assets and liabilities in both years
Taxes- Increased adjusted earnings by $41 million:
Favorable change in Japan - lower premium tax due to lower sales and tax benefits from higher foreign earnings taxed at lower rates in 2024
Favorable change in Korea - tax benefits due to lower dividend withholding tax as a result of a rate decrease and a tax audit settlement in 2024
Notable Items - Increased adjusted earnings by $53 million on a reported basis:
2024 notable item - unfavorable impact of $41 million - actuarial assumption review
2023 notable item - unfavorable impact of $94 million - actuarial assumption review
Business Overview. Adjusted premiums, fees and other revenues for the year ended December 31, 2024 increased $209 million, or 4%, compared to 2023. Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $544 million, or 10%, compared to 2023, mainly driven by strong sales and solid persistency across the region.
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Adjusted earnings | $881 | $840 |
| Adjusted earnings on a constant currency basis | $881 | $791 |
| Adjusted premiums, fees and other revenues | $5,936 | $5,727 |
| Adjusted premiums, fees and other revenues on a constant currency basis | $5,936 | $5,392 |
Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.
Adjusted Earnings - Increased $41 million on a reported basis, primarily due to the following business drivers:
Foreign Currency - Decreased adjusted earnings by $49 million:
Chilean and Mexican peso weakened against the U.S. dollar
Volume Growth - Increased adjusted earnings by $95 million:
Strong sales of single premium immediate annuities in Chile resulted in higher average invested assets
Higher sales, primarily in Mexico and Chile
Increase in interest credited expenses on long duration products
Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $22 million:
Favorable refinements to certain insurance liabilities primarily in Chile and Mexico
Expenses - Decreased adjusted earnings by $13 million:
Higher corporate-related and various other operating expenses, primarily in Mexico and Chile
Other - Decreased adjusted earnings by $15 million, includes
Higher amortization of DAC
Notable Items - Increased adjusted earnings by $4 million:
2024 notable item - favorable impact of $4 million - actuarial assumption review
EMEA
Business Overview. Adjusted premiums, fees and other revenues for the year ended December 31, 2024 increased $202 million, or 9%, compared to 2023. Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $277 million, or 12%, compared to 2023 primarily due to increases in our (i) corporate solutions business in the Gulf, the U.K. and Egypt, (ii) credit life and pension businesses in Turkey and Romania, and (iii) accident & health business across the region.
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Adjusted earnings | $283 | $265 |
| Adjusted earnings on a constant currency basis | $283 | $253 |
| Adjusted premiums, fees and other revenues | $2,548 | $2,346 |
| Adjusted premiums, fees and other revenues on a constant currency basis | $2,548 | $2,271 |
Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations. Foreign currency fluctuations can result in significant variances in the financial statement line items.
Adjusted Earnings- Increased $18 million on a reported basis, primarily due to the following business drivers:
Foreign Currency - Decreased adjusted earnings by $12 million:
Turkish lira and Egyptian pound weakened against the U.S. dollar
Market Factors - Increased adjusted earnings by $29 million:
Recurring investment income increased - higher yields on fixed income securities
Volume Growth - Increased adjusted earnings by $51 million:
Increase in sales and business growth of:
Credit life and pension businesses in Turkey and Romania
Corporate solutions business in the Gulf, the U.K. and Egypt
Accident & health business across the region
Underwriting and Other Insurance Adjustments - Decreased adjusted earnings by $4 million:
Unfavorable change from refinements to certain insurance liabilities in both years
Favorable underwriting experience across the region
Expenses- Decreased adjusted earnings by $36 million:
Higher direct expenses, including employee-related costs and various other operating expenses across the region
Taxes- Increased adjusted earnings by $13 million
Tax-related adjustments in both years
Notable Items- Decreased adjusted earnings by $23 million on a reported basis:
2024 notable item - unfavorable impact of $5 million - actuarial assumption review
2023 notable items - favorable impact of $18 million - actuarial assumption review and other insurance adjustments
Business Overview. The MetLife Holdings segment consists of operations relating to products and businesses, previously included in our former retail business, that we no longer actively market in the U.S. As anticipated, adjusted premiums, fees and other revenues continue to decline from expected business run-off. In addition, see Note 9 of the Notes to the Consolidated Financial Statements for information on a transaction to reinsure an in-force block of this business.
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Adjusted earnings | $647 | $733 |
| Adjusted premiums, fees and other revenues | $3,272 | $3,708 |
Adjusted Earnings - Decreased $86 million primarily due to the following business drivers:
Reinsurance Transaction - Decreased adjusted earnings by approximately $170 million as a result of the reinsurance transaction that closed in November 2023
Market Factors - Increased adjusted earnings by $73 million:
Variable investment income increased- higher returns on private equity funds
Decrease in interest credited expenses on long duration products
Recurring investment income decreased - lower average invested assets due to business run-off and lower income on derivatives, largely offset by higher yields on fixed income securities
Volume Growth - Decreased adjusted earnings by $40 million, consistent with business run-off
Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $28 million:
Favorable morbidity experience in our long-term care business
Lower dividend expense due to business run-off
Notable Items - Increased adjusted earnings by $10 million:
2024 notable items - favorable impact of $12 million- actuarial assumption review and other insurance adjustments
2023 notable items - favorable impact of $2 million- actuarial assumption review, largely offset by other insurance adjustments
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Adjusted earnings available to common shareholders | $(909) | $(958) |
| Adjusted premiums, fees and other revenues | $402 | $455 |
The table below presents adjusted earnings available to common shareholders by source:
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| (In millions) | ||
| Business activities | $72 | $87 |
| Net investment income | 416 | 353 |
| Interest expense on debt | (1,033) | (1,047) |
| Corporate initiatives and projects | (33) | (67) |
| Other | (306) | (493) |
| Provision for income tax (expense) benefit and other tax-related items | 175 | 407 |
| Preferred stock dividends | (200) | (198) |
| Adjusted earnings available to common shareholders | $(909) | $(958) |
Adjusted Earnings Available to Common Shareholders- Increased $49 million primarily due to the following:
Business Activities - Decreased adjusted earnings available to common shareholders by $12 million:
Lower revenues in certain of our businesses
Net Investment Income - Increased adjusted earnings available to common shareholders by $50 million:
Recurring investment income increased - the impact of tax equity investments now accounted for under the proportional amortization method, partially offset by lower yields on fixed income securities and lower average invested assets
Variable investment income increased - higher returns on corporate debt funds
Interest Expense on Debt - Increased adjusted earnings available to common shareholders by $11 million:
Surplus notes repayments at maturity in January and February 2024
Senior note repayment at maturity in April 2024
Early senior note redemption in February 2023 and April 2024
Interest rate decrease on surplus notes
Senior note issuances in July 2023, March 2024, June 2024 and September 2024
Corporate Initiatives and Projects & Other – Increased adjusted earnings available to common shareholders by $175 million:
Interest associated with a tax refund in 2024 (notable item)
Lower corporate and employee-related expenses, including from initiatives and projects
Litigation reserves increased less in 2024 compared to 2023 (includes notable items in both years)
Taxes - Unfavorable change in Corporate & Other’s taxes:
Lower tax preferenced items, primarily due to the impact of tax equity investments now accounted for under the proportional amortization method
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.